

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glyoxylate metabolic process (GO:0046487) | 5.00177060 |
| 2 | L-phenylalanine metabolic process (GO:0006558) | 4.75726662 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.75726662 |
| 4 | tryptophan catabolic process (GO:0006569) | 4.70943661 |
| 5 | indole-containing compound catabolic process (GO:0042436) | 4.70943661 |
| 6 | indolalkylamine catabolic process (GO:0046218) | 4.70943661 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 4.68623262 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 4.67652905 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.67652905 |
| 10 | exogenous drug catabolic process (GO:0042738) | 4.60452056 |
| 11 | tryptophan metabolic process (GO:0006568) | 4.41567488 |
| 12 | sulfur amino acid catabolic process (GO:0000098) | 4.09362709 |
| 13 | urate metabolic process (GO:0046415) | 4.02979707 |
| 14 | serine family amino acid catabolic process (GO:0009071) | 4.02522590 |
| 15 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.99268371 |
| 16 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.96189153 |
| 17 | kynurenine metabolic process (GO:0070189) | 3.95529913 |
| 18 | aldehyde catabolic process (GO:0046185) | 3.95283814 |
| 19 | amino-acid betaine metabolic process (GO:0006577) | 3.92640540 |
| 20 | urea cycle (GO:0000050) | 3.86333090 |
| 21 | urea metabolic process (GO:0019627) | 3.86333090 |
| 22 | lysine metabolic process (GO:0006553) | 3.85521190 |
| 23 | lysine catabolic process (GO:0006554) | 3.85521190 |
| 24 | drug transmembrane transport (GO:0006855) | 3.81089007 |
| 25 | bile acid biosynthetic process (GO:0006699) | 3.78110701 |
| 26 | cysteine metabolic process (GO:0006534) | 3.76482507 |
| 27 | NAD biosynthetic process (GO:0009435) | 3.71791688 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 3.64937785 |
| 29 | positive regulation of fatty acid oxidation (GO:0046321) | 3.58557136 |
| 30 | cellular glucuronidation (GO:0052695) | 3.57986498 |
| 31 | amine catabolic process (GO:0009310) | 3.57936584 |
| 32 | cellular biogenic amine catabolic process (GO:0042402) | 3.57936584 |
| 33 | drug transport (GO:0015893) | 3.56526028 |
| 34 | glycine metabolic process (GO:0006544) | 3.56020909 |
| 35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.55127038 |
| 36 | serine family amino acid metabolic process (GO:0009069) | 3.51708356 |
| 37 | homocysteine metabolic process (GO:0050667) | 3.50574339 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 3.50283628 |
| 39 | uronic acid metabolic process (GO:0006063) | 3.48381073 |
| 40 | glucuronate metabolic process (GO:0019585) | 3.48381073 |
| 41 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.47479883 |
| 42 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.47479883 |
| 43 | carnitine metabolic process (GO:0009437) | 3.45301491 |
| 44 | L-fucose catabolic process (GO:0042355) | 3.41370144 |
| 45 | fucose catabolic process (GO:0019317) | 3.41370144 |
| 46 | L-fucose metabolic process (GO:0042354) | 3.41370144 |
| 47 | epoxygenase P450 pathway (GO:0019373) | 3.40086441 |
| 48 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.39077410 |
| 49 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.39077410 |
| 50 | serine family amino acid biosynthetic process (GO:0009070) | 3.36578991 |
| 51 | alpha-amino acid catabolic process (GO:1901606) | 3.32213790 |
| 52 | indolalkylamine metabolic process (GO:0006586) | 3.28931491 |
| 53 | arginine metabolic process (GO:0006525) | 3.27292123 |
| 54 | intestinal cholesterol absorption (GO:0030299) | 3.24198463 |
| 55 | response to nitrosative stress (GO:0051409) | 3.24101817 |
| 56 | imidazole-containing compound metabolic process (GO:0052803) | 3.23728772 |
| 57 | valine metabolic process (GO:0006573) | 3.21199404 |
| 58 | cellular amino acid catabolic process (GO:0009063) | 3.20936666 |
| 59 | cellular modified amino acid catabolic process (GO:0042219) | 3.20243960 |
| 60 | branched-chain amino acid catabolic process (GO:0009083) | 3.19667805 |
| 61 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.17293010 |
| 62 | fatty acid beta-oxidation (GO:0006635) | 3.17197853 |
| 63 | iron coordination entity transport (GO:1901678) | 3.13455301 |
| 64 | low-density lipoprotein particle remodeling (GO:0034374) | 3.13383305 |
| 65 | negative regulation of fibrinolysis (GO:0051918) | 3.12941424 |
| 66 | branched-chain amino acid metabolic process (GO:0009081) | 3.12278312 |
| 67 | regulation of fibrinolysis (GO:0051917) | 3.12080751 |
| 68 | benzene-containing compound metabolic process (GO:0042537) | 3.12037504 |
| 69 | flavonoid metabolic process (GO:0009812) | 3.10431694 |
| 70 | interkinetic nuclear migration (GO:0022027) | 3.09316303 |
| 71 | alpha-linolenic acid metabolic process (GO:0036109) | 3.07942608 |
| 72 | regulation of cholesterol esterification (GO:0010872) | 3.07279525 |
| 73 | bile acid metabolic process (GO:0008206) | 3.07232243 |
| 74 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.06997865 |
| 75 | short-chain fatty acid metabolic process (GO:0046459) | 3.05516104 |
| 76 | carboxylic acid catabolic process (GO:0046395) | 3.05369767 |
| 77 | organic acid catabolic process (GO:0016054) | 3.05369767 |
| 78 | DNA deamination (GO:0045006) | 3.02587496 |
| 79 | mannose metabolic process (GO:0006013) | 3.01464818 |
| 80 | protein carboxylation (GO:0018214) | 3.00516146 |
| 81 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.00516146 |
| 82 | intestinal absorption (GO:0050892) | 2.98742989 |
| 83 | killing of cells of other organism (GO:0031640) | 2.98491071 |
| 84 | disruption of cells of other organism (GO:0044364) | 2.98491071 |
| 85 | high-density lipoprotein particle remodeling (GO:0034375) | 2.97112382 |
| 86 | fatty acid oxidation (GO:0019395) | 2.96712187 |
| 87 | fatty acid catabolic process (GO:0009062) | 2.95964583 |
| 88 | xenobiotic catabolic process (GO:0042178) | 2.95667148 |
| 89 | regulation of protein activation cascade (GO:2000257) | 2.94997719 |
| 90 | lipid oxidation (GO:0034440) | 2.93751297 |
| 91 | drug catabolic process (GO:0042737) | 2.93469676 |
| 92 | oxidative demethylation (GO:0070989) | 2.92551566 |
| 93 | arginine catabolic process (GO:0006527) | 2.92467904 |
| 94 | monocarboxylic acid catabolic process (GO:0072329) | 2.91226295 |
| 95 | macroautophagy (GO:0016236) | 2.90442602 |
| 96 | protein-lipid complex remodeling (GO:0034368) | 2.88085905 |
| 97 | macromolecular complex remodeling (GO:0034367) | 2.88085905 |
| 98 | plasma lipoprotein particle remodeling (GO:0034369) | 2.88085905 |
| 99 | proline metabolic process (GO:0006560) | 2.86183020 |
| 100 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.86181238 |
| 101 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.86181238 |
| 102 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.84267872 |
| 103 | regulation of complement activation (GO:0030449) | 2.83622472 |
| 104 | coenzyme catabolic process (GO:0009109) | 2.83232491 |
| 105 | lipoprotein metabolic process (GO:0042157) | 2.81988135 |
| 106 | regulation of triglyceride catabolic process (GO:0010896) | 2.81408419 |
| 107 | negative regulation of cholesterol transport (GO:0032375) | 2.78121253 |
| 108 | negative regulation of sterol transport (GO:0032372) | 2.78121253 |
| 109 | phospholipid efflux (GO:0033700) | 2.77510096 |
| 110 | fatty acid transmembrane transport (GO:1902001) | 2.76831503 |
| 111 | plasma lipoprotein particle organization (GO:0071827) | 2.75850735 |
| 112 | drug metabolic process (GO:0017144) | 2.75766278 |
| 113 | positive regulation of lipid catabolic process (GO:0050996) | 2.72675488 |
| 114 | ketone body metabolic process (GO:1902224) | 2.72226928 |
| 115 | reverse cholesterol transport (GO:0043691) | 2.72043641 |
| 116 | bile acid and bile salt transport (GO:0015721) | 2.71674192 |
| 117 | cholesterol efflux (GO:0033344) | 2.71561175 |
| 118 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.71501641 |
| 119 | blood coagulation, intrinsic pathway (GO:0007597) | 2.71312490 |
| 120 | cofactor catabolic process (GO:0051187) | 2.69371154 |
| 121 | tricarboxylic acid metabolic process (GO:0072350) | 2.68701124 |
| 122 | cellular ketone body metabolic process (GO:0046950) | 2.68493849 |
| 123 | organic cation transport (GO:0015695) | 2.68299416 |
| 124 | NAD metabolic process (GO:0019674) | 2.68153951 |
| 125 | pentose metabolic process (GO:0019321) | 2.68005164 |
| 126 | phospholipid homeostasis (GO:0055091) | 2.67975812 |
| 127 | triglyceride homeostasis (GO:0070328) | 2.67762824 |
| 128 | acylglycerol homeostasis (GO:0055090) | 2.67762824 |
| 129 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.65613822 |
| 130 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.64981364 |
| 131 | complement activation, alternative pathway (GO:0006957) | 2.62326399 |
| 132 | protein-lipid complex subunit organization (GO:0071825) | 2.55301090 |
| 133 | cellular response to ethanol (GO:0071361) | 2.53374007 |
| 134 | sodium-independent organic anion transport (GO:0043252) | 2.52768604 |
| 135 | regulation of cholesterol homeostasis (GO:2000188) | 2.49384220 |
| 136 | plasma lipoprotein particle assembly (GO:0034377) | 2.48145840 |
| 137 | hormone catabolic process (GO:0042447) | 2.47348530 |
| 138 | omega-hydroxylase P450 pathway (GO:0097267) | 2.46509840 |
| 139 | transepithelial transport (GO:0070633) | 2.40452355 |
| 140 | negative regulation of sodium ion transport (GO:0010766) | 2.40286924 |
| 141 | plasma lipoprotein particle clearance (GO:0034381) | 2.39622382 |
| 142 | sulfation (GO:0051923) | 2.39315614 |
| 143 | alkaloid metabolic process (GO:0009820) | 2.37214842 |
| 144 | cellular response to exogenous dsRNA (GO:0071360) | 2.36599530 |
| 145 | negative regulation of fatty acid transport (GO:2000192) | 2.34698332 |
| 146 | fucosylation (GO:0036065) | 2.34526867 |
| 147 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.33656894 |
| 148 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.33656894 |
| 149 | endocrine process (GO:0050886) | 2.33656894 |
| 150 | regulation of female gonad development (GO:2000194) | 2.32840709 |
| 151 | regulation of hippo signaling (GO:0035330) | 2.31723664 |
| 152 | regulation of fatty acid oxidation (GO:0046320) | 2.28215173 |
| 153 | ethanol oxidation (GO:0006069) | 2.28120992 |
| 154 | alanine transport (GO:0032328) | 2.27811454 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.72516478 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.44156235 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.11136689 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.61186805 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.13364943 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.08321411 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.62045004 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.33505575 |
| 9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.04882230 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.94487603 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.87905383 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.66926795 |
| 13 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.46808498 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.40420038 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.30298171 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.28369978 |
| 17 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.17483914 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.13853733 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.09349203 |
| 20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.07549634 |
| 21 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.06866735 |
| 22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.05746740 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.02137414 |
| 24 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.99327989 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95972919 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.95096939 |
| 27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.91143604 |
| 28 | VDR_22108803_ChIP-Seq_LS180_Human | 1.88686366 |
| 29 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.88578140 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86028150 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.83438092 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.81521080 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.79731351 |
| 34 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.77204483 |
| 35 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.68688107 |
| 36 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.66616804 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.65226065 |
| 38 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64634497 |
| 39 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.64571532 |
| 40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61154664 |
| 41 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.56657543 |
| 42 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.56348871 |
| 43 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.54890512 |
| 44 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54245523 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53417823 |
| 46 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.53368361 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.51769000 |
| 48 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.51090480 |
| 49 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.48240832 |
| 50 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.43532145 |
| 51 | * TP53_16413492_ChIP-PET_HCT116_Human | 1.43164311 |
| 52 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.42129340 |
| 53 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.41960489 |
| 54 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41768933 |
| 55 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.41193479 |
| 56 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.34088055 |
| 57 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34022199 |
| 58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.32229212 |
| 59 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.31034797 |
| 60 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.30915931 |
| 61 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.30609824 |
| 62 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.29284015 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28480117 |
| 64 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.26162372 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.26077938 |
| 66 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.25561391 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24701849 |
| 68 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.23636136 |
| 69 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.23161822 |
| 70 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23030061 |
| 71 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.22984866 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22737603 |
| 73 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19000364 |
| 74 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.18461609 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18278801 |
| 76 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16916387 |
| 77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15452638 |
| 78 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.14941609 |
| 79 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14879529 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13465023 |
| 81 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.12794984 |
| 82 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.12031601 |
| 83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11840696 |
| 84 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08993928 |
| 85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08528978 |
| 86 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07451223 |
| 87 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.07351911 |
| 88 | AR_20517297_ChIP-Seq_VCAP_Human | 1.06498865 |
| 89 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06071685 |
| 90 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06024805 |
| 91 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05504319 |
| 92 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.03970057 |
| 93 | ERA_21632823_ChIP-Seq_H3396_Human | 1.03861044 |
| 94 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.03592767 |
| 95 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.03545360 |
| 96 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.03130787 |
| 97 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02987810 |
| 98 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02706928 |
| 99 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02409365 |
| 100 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.02191852 |
| 101 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.02070663 |
| 102 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01656771 |
| 103 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01255525 |
| 104 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.00791401 |
| 105 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99753976 |
| 106 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.99491410 |
| 107 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.98781223 |
| 108 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95594282 |
| 109 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.94909211 |
| 110 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.94565220 |
| 111 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.94530770 |
| 112 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.94461733 |
| 113 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92834381 |
| 114 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.92643339 |
| 115 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.92166843 |
| 116 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.91752274 |
| 117 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91311831 |
| 118 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90458486 |
| 119 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.90440230 |
| 120 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.89908186 |
| 121 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.88924201 |
| 122 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.86911174 |
| 123 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.86209544 |
| 124 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86050308 |
| 125 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.85559912 |
| 126 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.85494946 |
| 127 | SPI1_23127762_ChIP-Seq_K562_Human | 0.85357449 |
| 128 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.85188901 |
| 129 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85131658 |
| 130 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.84598675 |
| 131 | TCF4_23295773_ChIP-Seq_U87_Human | 0.84335660 |
| 132 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.84237399 |
| 133 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.84179175 |
| 134 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84043866 |
| 135 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83542856 |
| 136 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83369326 |
| 137 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.83354042 |
| 138 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81839038 |
| 139 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.81786765 |
| 140 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.81114971 |
| 141 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.81109981 |
| 142 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.81017442 |
| 143 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.80499061 |
| 144 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.80447069 |
| 145 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.80357055 |
| 146 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.80328648 |
| 147 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.80067244 |
| 148 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.79981383 |
| 149 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.79516020 |
| 150 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79487436 |
| 151 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.78628742 |
| 152 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.78596295 |
| 153 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.78078684 |
| 154 | * OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.77905856 |
| 155 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.77815924 |
| 156 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.77749615 |
| 157 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77745123 |
| 158 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.77517430 |
| 159 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.77467150 |
| 160 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.77269061 |
| 161 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77010154 |
| 162 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.76763372 |
| 163 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.76578517 |
| 164 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.76350695 |
| 165 | RXR_22108803_ChIP-Seq_LS180_Human | 0.76086614 |
| 166 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.75564285 |
| 167 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.75329413 |
| 168 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.75286961 |
| 169 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.75135213 |
| 170 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.74878738 |
| 171 | P300_27268052_Chip-Seq_Bcells_Human | 0.74584655 |
| 172 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.74584612 |
| 173 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.74528262 |
| 174 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.74328321 |
| 175 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.74204164 |
| 176 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.74014862 |
| 177 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.73417930 |
| 178 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.72883861 |
| 179 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.72830361 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.61421330 |
| 2 | MP0005360_urolithiasis | 5.75414903 |
| 3 | MP0005365_abnormal_bile_salt | 4.08387300 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.99826519 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.56732116 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.32632259 |
| 7 | MP0009379_abnormal_foot_pigmentation | 2.94720009 |
| 8 | MP0005332_abnormal_amino_acid | 2.85395661 |
| 9 | MP0003252_abnormal_bile_duct | 2.58021591 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.41039182 |
| 11 | MP0004130_abnormal_muscle_cell | 2.26172957 |
| 12 | MP0004019_abnormal_vitamin_homeostasis | 2.13847088 |
| 13 | MP0003186_abnormal_redox_activity | 2.10506916 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.07459072 |
| 15 | MP0003195_calcinosis | 2.06351755 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.05024670 |
| 17 | MP0001666_abnormal_nutrient_absorption | 1.99686883 |
| 18 | MP0002876_abnormal_thyroid_physiology | 1.98890390 |
| 19 | MP0005174_abnormal_tail_pigmentation | 1.90196653 |
| 20 | MP0005075_abnormal_melanosome_morpholog | 1.89643312 |
| 21 | MP0003879_abnormal_hair_cell | 1.89240129 |
| 22 | MP0009840_abnormal_foam_cell | 1.88861967 |
| 23 | MP0009643_abnormal_urine_homeostasis | 1.86637312 |
| 24 | MP0005645_abnormal_hypothalamus_physiol | 1.80839442 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.73342654 |
| 26 | MP0001764_abnormal_homeostasis | 1.72253335 |
| 27 | MP0003724_increased_susceptibility_to | 1.60626368 |
| 28 | MP0008872_abnormal_physiological_respon | 1.58866365 |
| 29 | MP0003011_delayed_dark_adaptation | 1.58811466 |
| 30 | MP0001501_abnormal_sleep_pattern | 1.58715956 |
| 31 | MP0005167_abnormal_blood-brain_barrier | 1.56683793 |
| 32 | MP0003045_fibrosis | 1.54997823 |
| 33 | MP0005636_abnormal_mineral_homeostasis | 1.52721764 |
| 34 | MP0003436_decreased_susceptibility_to | 1.50975827 |
| 35 | MP0005084_abnormal_gallbladder_morpholo | 1.50484204 |
| 36 | MP0004145_abnormal_muscle_electrophysio | 1.49040556 |
| 37 | MP0001835_abnormal_antigen_presentation | 1.45665147 |
| 38 | MP0003868_abnormal_feces_composition | 1.45426512 |
| 39 | MP0009697_abnormal_copulation | 1.44770092 |
| 40 | MP0000015_abnormal_ear_pigmentation | 1.43824559 |
| 41 | MP0005408_hypopigmentation | 1.42462674 |
| 42 | MP0000609_abnormal_liver_physiology | 1.40028858 |
| 43 | MP0003136_yellow_coat_color | 1.31850701 |
| 44 | MP0003646_muscle_fatigue | 1.27375032 |
| 45 | MP0009785_altered_susceptibility_to | 1.26558438 |
| 46 | MP0001853_heart_inflammation | 1.26169197 |
| 47 | MP0000569_abnormal_digit_pigmentation | 1.23816904 |
| 48 | MP0006292_abnormal_olfactory_placode | 1.23639289 |
| 49 | MP0001873_stomach_inflammation | 1.23633522 |
| 50 | MP0008469_abnormal_protein_level | 1.21911401 |
| 51 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.20508833 |
| 52 | MP0009764_decreased_sensitivity_to | 1.19305154 |
| 53 | MP0002118_abnormal_lipid_homeostasis | 1.19294611 |
| 54 | MP0004381_abnormal_hair_follicle | 1.18493241 |
| 55 | MP0005409_darkened_coat_color | 1.15552404 |
| 56 | MP0008775_abnormal_heart_ventricle | 1.15410878 |
| 57 | MP0005058_abnormal_lysosome_morphology | 1.13539991 |
| 58 | MP0005083_abnormal_biliary_tract | 1.12029529 |
| 59 | MP0000371_diluted_coat_color | 1.11988594 |
| 60 | MP0002971_abnormal_brown_adipose | 1.11578453 |
| 61 | MP0005451_abnormal_body_composition | 1.09404260 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 1.07584232 |
| 63 | MP0005220_abnormal_exocrine_pancreas | 1.06364666 |
| 64 | MP0005448_abnormal_energy_balance | 1.06192479 |
| 65 | MP0000566_synostosis | 1.05663793 |
| 66 | MP0000685_abnormal_immune_system | 1.04644594 |
| 67 | MP0005551_abnormal_eye_electrophysiolog | 1.04221915 |
| 68 | MP0003866_abnormal_defecation | 1.03759280 |
| 69 | MP0000678_abnormal_parathyroid_gland | 1.03163563 |
| 70 | MP0002136_abnormal_kidney_physiology | 1.02839782 |
| 71 | MP0004147_increased_porphyrin_level | 1.01975790 |
| 72 | MP0000598_abnormal_liver_morphology | 1.01344810 |
| 73 | MP0000372_irregular_coat_pigmentation | 1.01323082 |
| 74 | MP0004885_abnormal_endolymph | 1.01021106 |
| 75 | MP0009115_abnormal_fat_cell | 1.00395841 |
| 76 | MP0002933_joint_inflammation | 0.99276857 |
| 77 | MP0000230_abnormal_systemic_arterial | 0.98084846 |
| 78 | MP0001756_abnormal_urination | 0.98055087 |
| 79 | MP0005025_abnormal_response_to | 0.97195510 |
| 80 | MP0002148_abnormal_hypersensitivity_rea | 0.96453689 |
| 81 | MP0001800_abnormal_humoral_immune | 0.96263370 |
| 82 | MP0001664_abnormal_digestion | 0.94852704 |
| 83 | MP0000490_abnormal_crypts_of | 0.94640763 |
| 84 | MP0002249_abnormal_larynx_morphology | 0.94618990 |
| 85 | MP0005334_abnormal_fat_pad | 0.94483246 |
| 86 | MP0002837_dystrophic_cardiac_calcinosis | 0.93990805 |
| 87 | MP0000604_amyloidosis | 0.93763038 |
| 88 | MP0005464_abnormal_platelet_physiology | 0.92853258 |
| 89 | MP0008961_abnormal_basal_metabolism | 0.90290461 |
| 90 | MP0004084_abnormal_cardiac_muscle | 0.90248694 |
| 91 | MP0003953_abnormal_hormone_level | 0.89728699 |
| 92 | MP0004036_abnormal_muscle_relaxation | 0.89341862 |
| 93 | MP0002078_abnormal_glucose_homeostasis | 0.88738669 |
| 94 | MP0009642_abnormal_blood_homeostasis | 0.88681969 |
| 95 | MP0001986_abnormal_taste_sensitivity | 0.87740249 |
| 96 | MP0005647_abnormal_sex_gland | 0.87550311 |
| 97 | MP0002419_abnormal_innate_immunity | 0.86969500 |
| 98 | MP0004043_abnormal_pH_regulation | 0.86529801 |
| 99 | MP0001790_abnormal_immune_system | 0.85961875 |
| 100 | MP0005387_immune_system_phenotype | 0.85961875 |
| 101 | MP0000681_abnormal_thyroid_gland | 0.84950898 |
| 102 | MP0009763_increased_sensitivity_to | 0.81548541 |
| 103 | MP0002168_other_aberrant_phenotype | 0.81003226 |
| 104 | MP0001845_abnormal_inflammatory_respons | 0.79862375 |
| 105 | MP0002909_abnormal_adrenal_gland | 0.79049412 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.78638248 |
| 107 | MP0002095_abnormal_skin_pigmentation | 0.77964407 |
| 108 | MP0004858_abnormal_nervous_system | 0.77643680 |
| 109 | MP0000249_abnormal_blood_vessel | 0.75851319 |
| 110 | MP0003632_abnormal_nervous_system | 0.75586306 |
| 111 | MP0003718_maternal_effect | 0.74613455 |
| 112 | MP0002733_abnormal_thermal_nociception | 0.74017231 |
| 113 | MP0003656_abnormal_erythrocyte_physiolo | 0.73888643 |
| 114 | MP0003283_abnormal_digestive_organ | 0.73807944 |
| 115 | MP0005670_abnormal_white_adipose | 0.73506905 |
| 116 | MP0010155_abnormal_intestine_physiology | 0.73279326 |
| 117 | MP0005376_homeostasis/metabolism_phenot | 0.73092832 |
| 118 | MP0003329_amyloid_beta_deposits | 0.72335496 |
| 119 | MP0000013_abnormal_adipose_tissue | 0.72283099 |
| 120 | MP0002075_abnormal_coat/hair_pigmentati | 0.71777286 |
| 121 | MP0003959_abnormal_lean_body | 0.71034462 |
| 122 | MP0002135_abnormal_kidney_morphology | 0.69881978 |
| 123 | MP0002089_abnormal_postnatal_growth/wei | 0.69717346 |
| 124 | MP0002396_abnormal_hematopoietic_system | 0.69493291 |
| 125 | MP0009333_abnormal_splenocyte_physiolog | 0.69405138 |
| 126 | MP0003638_abnormal_response/metabolism_ | 0.69321851 |
| 127 | MP0005646_abnormal_pituitary_gland | 0.68745598 |
| 128 | MP0001502_abnormal_circadian_rhythm | 0.68705374 |
| 129 | MP0001186_pigmentation_phenotype | 0.68311055 |
| 130 | MP0002928_abnormal_bile_duct | 0.67571420 |
| 131 | MP0004142_abnormal_muscle_tone | 0.67508965 |
| 132 | MP0002723_abnormal_immune_serum | 0.66030609 |
| 133 | MP0005535_abnormal_body_temperature | 0.65917543 |
| 134 | MP0001765_abnormal_ion_homeostasis | 0.65778668 |
| 135 | MP0003183_abnormal_peptide_metabolism | 0.65313727 |
| 136 | MP0002132_abnormal_respiratory_system | 0.65239224 |
| 137 | MP0000049_abnormal_middle_ear | 0.65198867 |
| 138 | MP0002693_abnormal_pancreas_physiology | 0.65101077 |
| 139 | MP0003172_abnormal_lysosome_physiology | 0.64304303 |
| 140 | MP0010368_abnormal_lymphatic_system | 0.63653216 |
| 141 | MP0001188_hyperpigmentation | 0.63301618 |
| 142 | MP0008260_abnormal_autophagy | 0.62426075 |
| 143 | MP0000343_altered_response_to | 0.61626068 |
| 144 | MP0005595_abnormal_vascular_smooth | 0.61530521 |
| 145 | MP0003763_abnormal_thymus_physiology | 0.60045178 |
| 146 | MP0000613_abnormal_salivary_gland | 0.59867084 |
| 147 | MP0001663_abnormal_digestive_system | 0.58178263 |
| 148 | MP0009053_abnormal_anal_canal | 0.57063056 |
| 149 | MP0009384_cardiac_valve_regurgitation | 0.56968861 |
| 150 | MP0005266_abnormal_metabolism | 0.56021054 |
| 151 | MP0005671_abnormal_response_to | 0.55005926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reduced antithrombin III activity (HP:0001976) | 5.85104355 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 4.79320532 |
| 3 | Type I transferrin isoform profile (HP:0003642) | 4.72646187 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.52273255 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.47655205 |
| 6 | Hyperglycinuria (HP:0003108) | 4.02396033 |
| 7 | Genetic anticipation (HP:0003743) | 4.00937986 |
| 8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.85298813 |
| 9 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.81472888 |
| 10 | Generalized aminoaciduria (HP:0002909) | 3.77339177 |
| 11 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.69438883 |
| 12 | Abnormal protein glycosylation (HP:0012346) | 3.67440078 |
| 13 | Abnormal glycosylation (HP:0012345) | 3.67440078 |
| 14 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.67440078 |
| 15 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.67440078 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 3.62086054 |
| 17 | Joint hemorrhage (HP:0005261) | 3.45091451 |
| 18 | Polydipsia (HP:0001959) | 3.43556961 |
| 19 | Abnormal drinking behavior (HP:0030082) | 3.43556961 |
| 20 | Hyperglycinemia (HP:0002154) | 3.42671121 |
| 21 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.42582024 |
| 22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.36790166 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 3.36790166 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.34293684 |
| 25 | Hyperammonemia (HP:0001987) | 3.31414119 |
| 26 | Congenital stationary night blindness (HP:0007642) | 3.26646228 |
| 27 | Large for gestational age (HP:0001520) | 3.23523531 |
| 28 | Late onset (HP:0003584) | 3.20814430 |
| 29 | Deep venous thrombosis (HP:0002625) | 3.17186166 |
| 30 | Tetany (HP:0001281) | 3.13875149 |
| 31 | Glycosuria (HP:0003076) | 3.09811690 |
| 32 | Abnormality of urine glucose concentration (HP:0011016) | 3.09811690 |
| 33 | Hepatic necrosis (HP:0002605) | 3.07203632 |
| 34 | Xanthomatosis (HP:0000991) | 3.02907510 |
| 35 | Proximal tubulopathy (HP:0000114) | 3.02090831 |
| 36 | Decreased circulating renin level (HP:0003351) | 3.00920789 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.00749760 |
| 38 | Ketosis (HP:0001946) | 2.98387550 |
| 39 | Dicarboxylic aciduria (HP:0003215) | 2.97883270 |
| 40 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.97883270 |
| 41 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.95632303 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 2.91341118 |
| 43 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.90273144 |
| 44 | Hypoglycemic coma (HP:0001325) | 2.87786492 |
| 45 | Clumsiness (HP:0002312) | 2.84192984 |
| 46 | Delayed CNS myelination (HP:0002188) | 2.84071750 |
| 47 | Abnormality of magnesium homeostasis (HP:0004921) | 2.79377308 |
| 48 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.78931743 |
| 49 | Hyperventilation (HP:0002883) | 2.78825024 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 2.75938353 |
| 51 | Pigmentary retinal degeneration (HP:0001146) | 2.67551625 |
| 52 | Hypochromic anemia (HP:0001931) | 2.66225787 |
| 53 | Hepatocellular necrosis (HP:0001404) | 2.64091145 |
| 54 | Hyperbilirubinemia (HP:0002904) | 2.63211473 |
| 55 | Progressive cerebellar ataxia (HP:0002073) | 2.61209108 |
| 56 | Lipid accumulation in hepatocytes (HP:0006561) | 2.60759262 |
| 57 | Increased muscle lipid content (HP:0009058) | 2.60047247 |
| 58 | Lethargy (HP:0001254) | 2.58836928 |
| 59 | Hypothermia (HP:0002045) | 2.56767554 |
| 60 | Abnormality of the common coagulation pathway (HP:0010990) | 2.56083732 |
| 61 | Abnormality of serum amino acid levels (HP:0003112) | 2.55681675 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.55073195 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.54026240 |
| 64 | Hypobetalipoproteinemia (HP:0003563) | 2.53830269 |
| 65 | Increased intramyocellular lipid droplets (HP:0012240) | 2.52748175 |
| 66 | Hemorrhage of the eye (HP:0011885) | 2.50218472 |
| 67 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.49933397 |
| 68 | Abnormal urine output (HP:0012590) | 2.48391171 |
| 69 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.46988577 |
| 70 | Ketoacidosis (HP:0001993) | 2.44513828 |
| 71 | Renal Fanconi syndrome (HP:0001994) | 2.44341934 |
| 72 | Hyperphosphaturia (HP:0003109) | 2.41318311 |
| 73 | Congenital sensorineural hearing impairment (HP:0008527) | 2.40259710 |
| 74 | Alkalosis (HP:0001948) | 2.39784277 |
| 75 | Polyuria (HP:0000103) | 2.35120756 |
| 76 | Increased hepatocellular lipid droplets (HP:0006565) | 2.34729542 |
| 77 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.33641471 |
| 78 | Abnormality of methionine metabolism (HP:0010901) | 2.33039640 |
| 79 | Vacuolated lymphocytes (HP:0001922) | 2.30217964 |
| 80 | Metabolic acidosis (HP:0001942) | 2.29869269 |
| 81 | Hyperlipoproteinemia (HP:0010980) | 2.29866786 |
| 82 | Cerebral palsy (HP:0100021) | 2.29509285 |
| 83 | Abnormality of purine metabolism (HP:0004352) | 2.29188088 |
| 84 | Thyroid-stimulating hormone excess (HP:0002925) | 2.28440789 |
| 85 | Fat malabsorption (HP:0002630) | 2.26954249 |
| 86 | Stomach cancer (HP:0012126) | 2.26469378 |
| 87 | Abnormality of the intrinsic pathway (HP:0010989) | 2.25968080 |
| 88 | Nausea (HP:0002018) | 2.25152358 |
| 89 | Facial shape deformation (HP:0011334) | 2.22205250 |
| 90 | Potter facies (HP:0002009) | 2.22205250 |
| 91 | Dysmetric saccades (HP:0000641) | 2.21324244 |
| 92 | Gaze-evoked nystagmus (HP:0000640) | 2.21236851 |
| 93 | Gout (HP:0001997) | 2.19210987 |
| 94 | Renal tubular dysfunction (HP:0000124) | 2.19160717 |
| 95 | Opisthotonus (HP:0002179) | 2.15322292 |
| 96 | Chronic diarrhea (HP:0002028) | 2.15164113 |
| 97 | Cerebral edema (HP:0002181) | 2.14412152 |
| 98 | Abnormality of binocular vision (HP:0011514) | 2.13936265 |
| 99 | Diplopia (HP:0000651) | 2.13936265 |
| 100 | Hypomagnesemia (HP:0002917) | 2.11763446 |
| 101 | Pancreatitis (HP:0001733) | 2.10151564 |
| 102 | Abnormal urine phosphate concentration (HP:0012599) | 2.09224950 |
| 103 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.09045268 |
| 104 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.09045268 |
| 105 | Abnormality of glycolipid metabolism (HP:0010969) | 2.09045268 |
| 106 | Abnormality of renal excretion (HP:0011036) | 2.08755643 |
| 107 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.08246354 |
| 108 | Abnormality of renal resorption (HP:0011038) | 2.07303682 |
| 109 | Fair hair (HP:0002286) | 2.06769423 |
| 110 | Microcytic anemia (HP:0001935) | 2.06436688 |
| 111 | Vomiting (HP:0002013) | 2.06137857 |
| 112 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.05353460 |
| 113 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.05353460 |
| 114 | Hyperactive renin-angiotensin system (HP:0000841) | 2.04929799 |
| 115 | Nephritis (HP:0000123) | 2.04803341 |
| 116 | Spontaneous abortion (HP:0005268) | 2.01644053 |
| 117 | Renal tubular acidosis (HP:0001947) | 2.01409724 |
| 118 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.01300765 |
| 119 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.01300765 |
| 120 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.01300765 |
| 121 | Complement deficiency (HP:0004431) | 2.00094519 |
| 122 | Protruding tongue (HP:0010808) | 2.00081954 |
| 123 | Reticulocytopenia (HP:0001896) | 1.99934700 |
| 124 | Mesangial abnormality (HP:0001966) | 1.99632262 |
| 125 | Vascular calcification (HP:0004934) | 1.98424320 |
| 126 | Hydroxyprolinuria (HP:0003080) | 1.97404517 |
| 127 | Abnormality of proline metabolism (HP:0010907) | 1.97404517 |
| 128 | Glomerulonephritis (HP:0000099) | 1.97219608 |
| 129 | Renal cortical cysts (HP:0000803) | 1.96943770 |
| 130 | Elevated hepatic transaminases (HP:0002910) | 1.95967226 |
| 131 | Arthropathy (HP:0003040) | 1.95678930 |
| 132 | Mucopolysacchariduria (HP:0008155) | 1.94947429 |
| 133 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94947429 |
| 134 | Abnormal number of erythroid precursors (HP:0012131) | 1.94333966 |
| 135 | Hypoplastic ischia (HP:0003175) | 1.93928118 |
| 136 | Abnormality of renin-angiotensin system (HP:0000847) | 1.92831959 |
| 137 | Exertional dyspnea (HP:0002875) | 1.92627394 |
| 138 | Hypolipoproteinemia (HP:0010981) | 1.92196060 |
| 139 | Abnormality of the renal cortex (HP:0011035) | 1.91363524 |
| 140 | Thrombocytosis (HP:0001894) | 1.90805912 |
| 141 | Conjugated hyperbilirubinemia (HP:0002908) | 1.89888976 |
| 142 | Increased purine levels (HP:0004368) | 1.88973191 |
| 143 | Hyperuricemia (HP:0002149) | 1.88973191 |
| 144 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87950844 |
| 145 | Metabolic alkalosis (HP:0200114) | 1.87188234 |
| 146 | Dysostosis multiplex (HP:0000943) | 1.85735335 |
| 147 | Decreased central vision (HP:0007663) | 1.84438591 |
| 148 | Abnormality of the axillary hair (HP:0100134) | 1.83190532 |
| 149 | Abnormality of secondary sexual hair (HP:0009888) | 1.83190532 |
| 150 | Epidermoid cyst (HP:0200040) | 1.83009088 |
| 151 | Hypercholesterolemia (HP:0003124) | 1.82436427 |
| 152 | Hypercalciuria (HP:0002150) | 1.81576078 |
| 153 | Malnutrition (HP:0004395) | 1.81205214 |
| 154 | Generalized hypopigmentation of hair (HP:0011358) | 1.81071494 |
| 155 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.80727684 |
| 156 | Cardiovascular calcification (HP:0011915) | 1.80710728 |
| 157 | Abnormality of complement system (HP:0005339) | 1.79689411 |
| 158 | Gingival bleeding (HP:0000225) | 1.78835014 |
| 159 | Steatorrhea (HP:0002570) | 1.76686735 |
| 160 | Enlarged kidneys (HP:0000105) | 1.75825953 |
| 161 | Enlarged epiphyses (HP:0010580) | 1.75824909 |
| 162 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.75463763 |
| 163 | Abolished electroretinogram (ERG) (HP:0000550) | 1.75315928 |
| 164 | Petechiae (HP:0000967) | 1.75310924 |
| 165 | Ileus (HP:0002595) | 1.75019517 |
| 166 | Attenuation of retinal blood vessels (HP:0007843) | 1.73776558 |
| 167 | Hemiplegia (HP:0002301) | 1.73394348 |
| 168 | Chorioretinal atrophy (HP:0000533) | 1.73250788 |
| 169 | Macroglossia (HP:0000158) | 1.73042315 |
| 170 | Abnormality of the wing of the ilium (HP:0011867) | 1.72751891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 4.90348956 |
| 2 | EIF2AK3 | 4.86742597 |
| 3 | FRK | 4.71916028 |
| 4 | BCKDK | 3.97198903 |
| 5 | TRIB3 | 3.32085705 |
| 6 | MUSK | 3.25454937 |
| 7 | ACVR1B | 3.02360250 |
| 8 | IRAK3 | 2.86723218 |
| 9 | NME2 | 2.64940349 |
| 10 | NLK | 2.45541187 |
| 11 | MKNK2 | 2.44590014 |
| 12 | STK16 | 2.23721682 |
| 13 | IRAK4 | 2.17900008 |
| 14 | PIM2 | 2.02257154 |
| 15 | BMPR1B | 2.01143034 |
| 16 | FLT3 | 1.98895818 |
| 17 | ERN1 | 1.93292353 |
| 18 | CAMKK2 | 1.83011345 |
| 19 | EIF2AK2 | 1.80900904 |
| 20 | MAPKAPK3 | 1.70933481 |
| 21 | EEF2K | 1.65912941 |
| 22 | MKNK1 | 1.65697479 |
| 23 | SIK2 | 1.57000101 |
| 24 | TLK1 | 1.46177058 |
| 25 | PIK3CA | 1.46155250 |
| 26 | SRPK1 | 1.37032928 |
| 27 | GRK1 | 1.34430027 |
| 28 | OBSCN | 1.33766486 |
| 29 | KIT | 1.33542577 |
| 30 | FGFR4 | 1.32566542 |
| 31 | YES1 | 1.32486510 |
| 32 | TGFBR2 | 1.30725275 |
| 33 | TBK1 | 1.26552176 |
| 34 | TEC | 1.24657934 |
| 35 | EPHA3 | 1.23207623 |
| 36 | CAMK1D | 1.23129940 |
| 37 | TYK2 | 1.22182869 |
| 38 | AKT3 | 1.20097044 |
| 39 | NEK9 | 1.19778927 |
| 40 | FGFR3 | 1.19410400 |
| 41 | MAP3K14 | 1.18394100 |
| 42 | TAOK2 | 1.17935069 |
| 43 | TIE1 | 1.13697896 |
| 44 | BTK | 1.13241713 |
| 45 | DAPK2 | 1.12685033 |
| 46 | IKBKB | 1.11587478 |
| 47 | PRPF4B | 1.09171201 |
| 48 | TRPM7 | 1.06481805 |
| 49 | IKBKE | 1.03735389 |
| 50 | MST1R | 1.03380100 |
| 51 | PTK6 | 1.02475989 |
| 52 | KDR | 1.02473217 |
| 53 | MAP2K3 | 1.01098045 |
| 54 | MATK | 0.99511369 |
| 55 | TNK2 | 0.97863519 |
| 56 | ZAK | 0.96576575 |
| 57 | ABL2 | 0.95087850 |
| 58 | PDPK1 | 0.91852549 |
| 59 | IRAK1 | 0.90994555 |
| 60 | CDK8 | 0.90723854 |
| 61 | PRKAA1 | 0.90477958 |
| 62 | PINK1 | 0.88181049 |
| 63 | PDK1 | 0.87302686 |
| 64 | RET | 0.84370680 |
| 65 | MYLK | 0.84240350 |
| 66 | PIM1 | 0.83906530 |
| 67 | MAPK12 | 0.83229604 |
| 68 | BUB1 | 0.81916951 |
| 69 | PIK3CG | 0.81217507 |
| 70 | ICK | 0.80763548 |
| 71 | CDK12 | 0.80646790 |
| 72 | CASK | 0.80073960 |
| 73 | WNK3 | 0.78403788 |
| 74 | STK39 | 0.77336426 |
| 75 | CSF1R | 0.75717178 |
| 76 | IRAK2 | 0.74818685 |
| 77 | PHKG1 | 0.74311118 |
| 78 | PHKG2 | 0.74311118 |
| 79 | SGK2 | 0.73116534 |
| 80 | NTRK3 | 0.73104843 |
| 81 | TAOK3 | 0.72180936 |
| 82 | RIPK4 | 0.72150843 |
| 83 | VRK1 | 0.72019418 |
| 84 | MAPK11 | 0.72002533 |
| 85 | WNK4 | 0.71130307 |
| 86 | OXSR1 | 0.70357542 |
| 87 | NUAK1 | 0.70312350 |
| 88 | FES | 0.69992076 |
| 89 | INSRR | 0.68417358 |
| 90 | LYN | 0.67986580 |
| 91 | CHUK | 0.67043461 |
| 92 | ITK | 0.66965060 |
| 93 | MAP2K1 | 0.66340768 |
| 94 | MST4 | 0.66014077 |
| 95 | CAMK1G | 0.65788044 |
| 96 | JAK1 | 0.65664848 |
| 97 | MAP4K1 | 0.65605128 |
| 98 | FGFR2 | 0.64384954 |
| 99 | ZAP70 | 0.63855388 |
| 100 | DYRK1B | 0.63515892 |
| 101 | MARK2 | 0.63473721 |
| 102 | PRKG2 | 0.63040617 |
| 103 | ERBB2 | 0.62711878 |
| 104 | SIK1 | 0.62390816 |
| 105 | PRKCQ | 0.61727373 |
| 106 | CLK1 | 0.60950498 |
| 107 | CAMKK1 | 0.60940490 |
| 108 | ADRBK1 | 0.60690922 |
| 109 | PTK2B | 0.59481042 |
| 110 | CDC42BPA | 0.58279590 |
| 111 | HCK | 0.55864203 |
| 112 | PRKCI | 0.55585425 |
| 113 | BLK | 0.55552513 |
| 114 | MAPK4 | 0.55311408 |
| 115 | PKN1 | 0.54139090 |
| 116 | TYRO3 | 0.52665170 |
| 117 | PRKCZ | 0.52052506 |
| 118 | MAP3K7 | 0.51398702 |
| 119 | EPHB1 | 0.50309867 |
| 120 | DYRK3 | 0.50076853 |
| 121 | LCK | 0.49960068 |
| 122 | PRKCH | 0.49933536 |
| 123 | MAP2K6 | 0.49718815 |
| 124 | TXK | 0.49636967 |
| 125 | PKN2 | 0.49043167 |
| 126 | SYK | 0.48778137 |
| 127 | ADRBK2 | 0.48697527 |
| 128 | SGK3 | 0.48371373 |
| 129 | GRK6 | 0.47898165 |
| 130 | CDK7 | 0.47847693 |
| 131 | MTOR | 0.47410382 |
| 132 | PRKD2 | 0.46942431 |
| 133 | HIPK2 | 0.46618542 |
| 134 | WNK1 | 0.46262588 |
| 135 | TGFBR1 | 0.46171146 |
| 136 | MAP2K2 | 0.42868405 |
| 137 | WEE1 | 0.41986737 |
| 138 | CSK | 0.40146280 |
| 139 | PRKAA2 | 0.40127872 |
| 140 | EIF2AK1 | 0.39680768 |
| 141 | MAPK15 | 0.38422754 |
| 142 | PAK4 | 0.36596234 |
| 143 | PRKCD | 0.36285381 |
| 144 | RPS6KA6 | 0.36232351 |
| 145 | RPS6KC1 | 0.35884636 |
| 146 | RPS6KL1 | 0.35884636 |
| 147 | CAMK1 | 0.34962101 |
| 148 | LRRK2 | 0.34565276 |
| 149 | STK38L | 0.33970487 |
| 150 | CDK4 | 0.33570374 |
| 151 | ERBB3 | 0.33479240 |
| 152 | EPHB2 | 0.32380061 |
| 153 | EPHA2 | 0.31761866 |
| 154 | CAMK4 | 0.30710042 |
| 155 | FER | 0.29695811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.36656614 |
| 2 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.10931186 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.99690556 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37672255 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.29638797 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.28821119 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.22727310 |
| 8 | Peroxisome_Homo sapiens_hsa04146 | 2.22220852 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.20774907 |
| 10 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.14797929 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.14510768 |
| 12 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.10520195 |
| 13 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.09241664 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.92853917 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.90648110 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.89695015 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.81318969 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.77442190 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.74421518 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.70921902 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.68840330 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.65073160 |
| 23 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.64885602 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.64870665 |
| 25 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.63976606 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62012387 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.59320354 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.57317972 |
| 29 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.51195934 |
| 30 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.48576614 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.47749734 |
| 32 | Ribosome_Homo sapiens_hsa03010 | 1.47585451 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45111867 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.43173399 |
| 35 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.43151288 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.41601879 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.40389615 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.39826281 |
| 39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.38451434 |
| 40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.36353049 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.35988860 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.29488987 |
| 43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.27773530 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27453625 |
| 45 | DNA replication_Homo sapiens_hsa03030 | 1.26152021 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.24741664 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.22686416 |
| 48 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.17164531 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11908638 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.11125999 |
| 51 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.11075071 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10691359 |
| 53 | Insulin resistance_Homo sapiens_hsa04931 | 1.10409422 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06663271 |
| 55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.06432810 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05979325 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.03654288 |
| 58 | Protein export_Homo sapiens_hsa03060 | 1.01817183 |
| 59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.97567022 |
| 60 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.96965638 |
| 61 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92644699 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.90674736 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.90620709 |
| 64 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.90041172 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.86817957 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.82375131 |
| 67 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.81458282 |
| 68 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.81215571 |
| 69 | Base excision repair_Homo sapiens_hsa03410 | 0.79936015 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.78707991 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78550284 |
| 72 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.75893376 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.75028149 |
| 74 | Salivary secretion_Homo sapiens_hsa04970 | 0.73426675 |
| 75 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.72801232 |
| 76 | Bile secretion_Homo sapiens_hsa04976 | 0.70862338 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.70550607 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.68628249 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68544056 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67279167 |
| 81 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.66287955 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65709329 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64307519 |
| 84 | Insulin secretion_Homo sapiens_hsa04911 | 0.64219379 |
| 85 | Lysosome_Homo sapiens_hsa04142 | 0.63698299 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62085104 |
| 87 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60926240 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60785145 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59979749 |
| 90 | Phototransduction_Homo sapiens_hsa04744 | 0.59567486 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59278098 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.59217224 |
| 93 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.58796750 |
| 94 | Mismatch repair_Homo sapiens_hsa03430 | 0.58682914 |
| 95 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58556941 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55730644 |
| 97 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55102359 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54992577 |
| 99 | Homologous recombination_Homo sapiens_hsa03440 | 0.54436434 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.54049279 |
| 101 | Morphine addiction_Homo sapiens_hsa05032 | 0.52875295 |
| 102 | Platelet activation_Homo sapiens_hsa04611 | 0.52050522 |
| 103 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51634829 |
| 104 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51144071 |
| 105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51069250 |
| 106 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50831233 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50475581 |
| 108 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49057053 |
| 109 | Allograft rejection_Homo sapiens_hsa05330 | 0.48756198 |
| 110 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48222691 |
| 111 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47260363 |
| 112 | Asthma_Homo sapiens_hsa05310 | 0.45460282 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45217823 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44817233 |
| 115 | Proteasome_Homo sapiens_hsa03050 | 0.40756181 |
| 116 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39864416 |
| 117 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.39621255 |
| 118 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.39393053 |
| 119 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.39081860 |
| 120 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.38823795 |
| 121 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.37903150 |
| 122 | Circadian entrainment_Homo sapiens_hsa04713 | 0.37404079 |
| 123 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37067925 |
| 124 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.36843971 |
| 125 | Thyroid cancer_Homo sapiens_hsa05216 | 0.35399422 |
| 126 | RNA polymerase_Homo sapiens_hsa03020 | 0.33011823 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31660355 |
| 128 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.31655109 |
| 129 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31028657 |
| 130 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30934703 |
| 131 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.29974301 |
| 132 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29647695 |
| 133 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.28849723 |
| 134 | Purine metabolism_Homo sapiens_hsa00230 | 0.26372594 |
| 135 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24529244 |
| 136 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.23255428 |
| 137 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.23215752 |
| 138 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.20631129 |
| 139 | Parkinsons disease_Homo sapiens_hsa05012 | 0.20312207 |
| 140 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.18604245 |
| 141 | Leishmaniasis_Homo sapiens_hsa05140 | 0.15129291 |
| 142 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.14813862 |
| 143 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14423515 |

